A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients
Clinical trial NCT03973112 · UNKNOWN
Trial details
- NCT number
- NCT03973112
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-24
- Primary completion
- 2022-06-15
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.